Phase II study of temozolomide (TMZ) administered on a 7 days on-7 days off regimen as primary treatment before radiotherapy (RT) in inoperable newly diagnosed glioblastoma multiforme (GBM)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 1523-1523
◽
Keyword(s):
Phase Ii
◽
2004 ◽
Vol 70
(3)
◽
pp. 359-370
◽